Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp

Bullboard Posts

Post by Canada2016on Feb 05, 2020 2:18pm

89 Views

Post# 30647289

Breathe

It's a two year study wait for news if it was bad they would not continue to implant patients plus I think people me anyways expected news a couple weeks ago and have lost patience I think they will be sorry it works in humans we already know that just need additional data to support the fact I think we are at four patients and will get 90 and 180 day data soon plus never know when a buyout or a partnership comes and call Robert M on bnn on Friday to see what he says plus the back and forth on SH is annoying and biotech can't decide if he's buying or selling be on the sidelines you will miss for sure plus it's not going to 0 in worst case scenario because what about thyroid and anemia

Bullboard Posts

Rich TV Live's Stocks to Watch this week (Nov. 22, 2024)